Jordi Servat-Codony
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Anticancer effects of an XPO1 inhibitor (selinexor) with sotorasib following omeprazole preconditioning in KRAS G12C-mutant non-small cell lung cancer cells in vitro and in a mouse tumor xenograft.
Journal: Neoplasia (New York, N.Y.)
Published: July 10, 2026
Cetuximab co-treatment with KRAS G12C inhibitors fulzerasib and sotorasib in human KRAS G12C non-small cell lung cancer cells.
Journal: Cell death discovery
Published: July 24, 2025
Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to in ovo investigation.
Journal: Frontiers in oncology
Published: June 12, 2025
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.
Journal: Lung Cancer (Auckland, N.Z.)
Published: January 23, 2024
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.
Journal: Cell communication and signaling : CCS
Published: December 04, 2023
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC).
Journal: Critical reviews in oncology/hematology
Published: November 30, 2023
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
Journal: Translational oncology
Published: October 30, 2023
Biological insights in non-small cell lung cancer.
Journal: Cancer biology & medicine
Published: June 29, 2023
The role of biomarkers in stage III non-small cell lung cancer.
Journal: Expert review of respiratory medicine
Published: June 15, 2023
Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer.
Journal: Translational cancer research
Published: December 27, 2022
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models.
Journal: Medical oncology (Northwood, London, England)
Published: June 14, 2022
Last Updated: 09/26/2026